Diagnosis and management of gout.
作者信息
Underwood Martin
机构信息
Department of General Practice and Primary Care, Centre for Health Sciences, University of London, London E1 2AT..
出版信息
BMJ. 2006 Jun 3;332(7553):1315-9. doi: 10.1136/bmj.332.7553.1315.
Abstract
摘要
相似文献
1
Diagnosis and management of gout.痛风的诊断与管理
BMJ. 2006 Jun 3;332(7553):1315-9. doi: 10.1136/bmj.332.7553.1315.
2
Gout.痛风
N Z Med J. 1994 Aug 24;107(984):337-9.
3
The management of gout: it should be crystal clear.痛风的管理：应该清晰明了。
J Rheumatol. 2006 Oct;33(10):1921-2.
4
Update on the management of hyperuricemia and gout.高尿酸血症与痛风管理的最新进展
Bull NYU Hosp Jt Dis. 2008;66(3):231-9.
5
[Gout].[痛风]
Ned Tijdschr Tandheelkd. 2000 Aug;107(8):344-5.
6
Diagnosis and management of acute gout.急性痛风的诊断与管理
Med Health R I. 2009 Nov;92(11):356-8.
7
[Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout].基于高尿酸血症和痛风管理指南的高尿酸血症和痛风治疗
Nihon Yakurigaku Zasshi. 2010 Dec;136(6):330-4. doi: 10.1254/fpj.136.330.
8
Hyperuricaemia and gout: clinical guideline 2003.高尿酸血症与痛风：2003年临床指南
S Afr Med J. 2003 Dec;93(12 Pt 2):961-71.
9
The treatment of gout.痛风的治疗。
J Fam Pract. 2012 Jun;61(6 Suppl):S11-5.
10
Gout Study Group: update on hyperuricemia and gout.痛风研究小组：高尿酸血症与痛风的最新进展。
Joint Bone Spine. 2009 Jul;76(4):444-6. doi: 10.1016/j.jbspin.2009.05.006. Epub 2009 Jun 25.
引用本文的文献
1
Combination of Uric Acid and Pro-Inflammatory Cytokines in Discriminating Patients with Gout from Healthy Controls.尿酸与促炎细胞因子联合用于区分痛风患者与健康对照者
J Inflamm Res. 2022 Feb 28;15:1413-1420. doi: 10.2147/JIR.S357159. eCollection 2022.
2
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods.天然和合成尿酸转运蛋白1抑制剂的最新进展及新型筛选方法
Evid Based Complement Alternat Med. 2021 Oct 31;2021:5738900. doi: 10.1155/2021/5738900. eCollection 2021.
3
Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.抗痛风药物与心血管疾病风险：一项巢式病例对照研究。
Front Med (Lausanne). 2021 Oct 18;8:739680. doi: 10.3389/fmed.2021.739680. eCollection 2021.
4
Impact of Coffee/Green Tea/Soft Drink Consumption on the Risk of Hyperuricemia: A Cross-Sectional Study.咖啡/绿茶/软饮料消费对高尿酸血症风险的影响：一项横断面研究。
Int J Environ Res Public Health. 2021 Jul 8;18(14):7299. doi: 10.3390/ijerph18147299.
5
Hyperuricemia and Cardiovascular Risk.高尿酸血症与心血管风险。
Cureus. 2021 May 5;13(5):e14855. doi: 10.7759/cureus.14855.
6
Association Between Use of Anti-gout Preparations and Dementia: Nested Case-Control Nationwide Population-Based Cohort Study.抗痛风制剂的使用与痴呆症之间的关联：基于全国人群队列的巢式病例对照研究。
Front Med (Lausanne). 2021 Jan 12;7:607808. doi: 10.3389/fmed.2020.607808. eCollection 2020.
7
Tophaceous gout in the sternoclavicular joint.胸锁关节痛风石性痛风
J Surg Case Rep. 2020 Oct 14;2020(10):rjaa398. doi: 10.1093/jscr/rjaa398. eCollection 2020 Oct.
8
A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout.非布司他与别嘌醇对比治疗中国高尿酸血症患者（伴或不伴痛风）的随机、双盲、非劣效性研究
Rheumatol Ther. 2019 Dec;6(4):543-557. doi: 10.1007/s40744-019-00173-8. Epub 2019 Sep 17.
9
Diagnostic accuracy of dual-energy CT in gout: a systematic review and meta-analysis.双能CT在痛风诊断中的准确性：一项系统评价和荟萃分析。
Skeletal Radiol. 2018 Dec;47(12):1587-1593. doi: 10.1007/s00256-018-2948-y. Epub 2018 May 3.
10
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.体内工程化唾液酸化致病性抗体可减轻自身免疫性疾病。
Cell. 2018 Jan 25;172(3):564-577.e13. doi: 10.1016/j.cell.2017.11.041. Epub 2017 Dec 21.
本文引用的文献
1
Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review.治疗急性痛风及预防痛风复发的干预措施的有效性——一项系统评价
Rheumatology (Oxford). 2006 Nov;45(11):1422-31. doi: 10.1093/rheumatology/kel071. Epub 2006 Apr 21.
2
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.非布司他与别嘌醇治疗高尿酸血症和痛风患者的比较。
N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373.
3
Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?血清尿酸与心血管疾病：最新进展以及我们从中得到了什么？
Am J Med. 2005 Aug;118(8):816-26. doi: 10.1016/j.amjmed.2005.03.043.
4
Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).医生对痛风和无症状高尿酸血症管理质量指标的依从性欠佳：来自英国全科医疗研究数据库（GPRD）的结果。
Rheumatology (Oxford). 2005 Aug;44(8):1038-42. doi: 10.1093/rheumatology/keh679. Epub 2005 May 3.
5
Gout: epidemiology and lifestyle choices.痛风：流行病学与生活方式选择
Curr Opin Rheumatol. 2005 May;17(3):341-5.
6
Recent advances in the management of gout and hyperuricemia.痛风与高尿酸血症治疗的最新进展
Curr Opin Rheumatol. 2005 May;17(3):319-24. doi: 10.1097/01.bor.0000162060.25895.a5.
7
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.男性肥胖、体重变化、高血压、利尿剂使用与痛风风险：健康专业人员随访研究
Arch Intern Med. 2005 Apr 11;165(7):742-8. doi: 10.1001/archinte.165.7.742.
8
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.痛风流行病学：英国全科医学研究数据库1990 - 1999年的研究结果
Ann Rheum Dis. 2005 Feb;64(2):267-72. doi: 10.1136/ard.2004.024091.
9
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.在开始使用别嘌醇治疗慢性痛风性关节炎时，使用秋水仙碱预防急性发作。
J Rheumatol. 2004 Dec;31(12):2429-32.
10
Gout: on the brink of novel therapeutic options for an ancient disease.痛风：古老疾病迎来新型治疗方案的曙光
Arthritis Rheum. 2004 Aug;50(8):2400-14. doi: 10.1002/art.20438.
Zotero 插件